“We are pleased to join these key market indexes,” said Brent M. Giles, Director and CEO of Hawthorn Bancshares, Inc. “Our inclusion in the Russell 3000 and the Russell 2000 is ...

FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes.

On June 30, 2025, Regeneron Pharmaceuticals (NasdaqGS:REGN) was removed from multiple key indices, a development that may influence its investment appeal and stock liquidity. Over the last month ...

On June 30, 2025, Regeneron Pharmaceuticals (NasdaqGS:REGN) was removed from multiple key indices, a development that may influence its investment appeal and stock liquidity. Over the last month, the ...

FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes.

Rezolve Ai achieved $70 million ARR, joined Russell indices, and formed partnerships with Microsoft and Google to enhance growth.

Sanofi and Regeneron Pharmaceuticals said they got Food and Drug Administration approval for anti-inflammatory drug Dupixent as a treatment for a rare skin disease, adding an eighth indication in ...

Co-founder Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron's offer for the DNA-testing company in a bankruptcy auction.

Global gold miner AngloGold Ashanti has been named for the first time as a preliminary addition to the Russell 1000 or Russell 2000, the Russell 3000 and the Russell Midcap Indexes, as part of the ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.

Regeneron Pharma stock has been in a persistent downtrend for over 280 days. Here's why you should avoid REGN.